VIGILVESTLibrary
← Library

Edwards Lifesciences Corp

EW
SEC CIK 1099800Price charts ↗
Writing the earnings story…

Financials

Revenue+16.7% YoY
$1.65B
Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Mar '26
Net Income+6.3% YoY
$380.7M
Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Mar '26
EPS (diluted)+8.2% YoY
$0.66
Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Mar '26
Gross Margin-0.8% YoY
78.0%
Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Mar '26
Quarter endingRevenueNet incomeEPS
Mar 2026$1.65B$380.7M$0.66
Sep 2025$1.55B$291.1M$0.5
Jun 2025$1.53B$333.2M$0.56
Mar 2025$1.41B$358.0M$0.61
Dec 2024$1.39B$385.6M$0.65
Sep 2024$1.35B$3.07B$5.13
Jun 2024$1.37B$366.3M$0.61
Mar 2024$1.33B$351.9M$0.58

Annual revenue

FY21FY22FY23FY24FY25

Source filings

Download the original reports from the SEC. A 10-Q is the quarterly update; a 10-K is the detailed annual report.

Glossary

Revenue
Net income
EPS
Gross margin
Net margin
Fiscal year

Hover any underlined term for its definition.